Lv1
18 积分 2022-11-25 加入
Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications
11小时前
待确认
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
2天前
已完结
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials
3天前
已完结
Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE)
3天前
已完结
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis
5天前
已完结
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
5天前
已完结
Alzheimer's drug lecanemab: FDA approves easier initial use, with "huge implications" for UK
7天前
已完结
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
11天前
已完结
A narrative review of serum biomarkers in progressive supranuclear palsy, corticobasal syndrome, and related disorders
12天前
已完结
The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosis
12天前
已完结
皖公网安备34019202002308
